Boundless Life

What Happens During A Psychedelic Journey: Dr. Matthew Johnson On Psychedelic Treatment Room, The State Of Psychedelic Research & Future of Psychedelic Therapy.

Jun 18, 2020
Dr. Matthew Johnson, a leading researcher on psychedelics from Johns Hopkins, dives into the transformative potential of psychedelic therapy. He discusses the urgent need for effective treatments for PTSD, particularly through MDMA-assisted psychotherapy. The conversation also touches on the challenges of fundraising for vital psychedelic research and the promising role of psilocybin in mental health. With a blend of humor and insight, Johnson addresses misconceptions and outlines the future landscape of psychedelic treatments and their therapeutic implications.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

Benefits for Healthy Individuals

  • Psychedelics can benefit "healthy normals" seeking self-optimization beyond addressing specific disorders.
  • Studies show positive changes in well-being and improved outcomes from practices like meditation.
INSIGHT

Microdosing Research

  • Microdosing research is limited, with current studies showing minimal benefits and slight impairment.
  • Anecdotal reports of enhanced performance and flow states need rigorous testing to verify effects beyond placebo.
ADVICE

Psilocybin for Tobacco Addiction

  • Psilocybin shows promise for treating tobacco addiction, with an 80% success rate in a pilot study.
  • This surpasses nicotine replacement therapies, showing potential as a more effective treatment.
Get the Snipd Podcast app to discover more snips from this episode
Get the app